Wen-Juei Jeng R. Increased incidence of HBsAg seroclearance in HBeAg negative chronic hepatitis B patients discontinued Nuc therapy comparing to natural course--a propensity score matched study. PS-158.
Bulevirtide veelbelovend tegen hepatitis D, maar nog veel vragen
jul 2021 | Hepatitis, Hepatologie